America’s weed smokers need more direction than ever. Gone are the days of one or two strains from your guy. A single store may carry 200...
Make some hot chocolate and settle in over winter break as Leafly’s Nick Jikomes, PhD, unshackles your mind from the chains of both THC and terpene...
2023 saw tons of new research come out related to cannabis. Below is a selection of some of the studies that caught my attention, with brief...
Strap in, Leafly nation—this one is going to be a doozy. Everyone in cannabis, as in any other industry or field, wants to be the best—but...
Add something special to your grow this season with the Queen’s own Another growing season is just around the corner, and intrepid cannabis cultivators across the...
One of the main reasons why I am such a vocal supporter of written cannabis contracts is allocation of risk and liabilities. Parties to a cannabis...
Here’s to a relaxing holiday with family and friends. Enjoy the holiday! We will be back next week with our regular programming. The post Happy Thanksgiving...
Cannabis companies that need more money than they can generate through sales generally have two options: borrow money (debt) or solicit investments (equity). Over the years...
Welcome to the eighth annual “State of the State” post on Oregon cannabis. Last year was memorable for Oregon the industry, pockmarked by OLCC scandal, heavy...
I stumbled upon this recent post by Jason Paltrowitz titled “Lawful but Awful: The Small Cap IPO Cycle.” It contains some interesting findings and I like...
